ARCHIVES

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

This article is from The Cancer Letter archive.

Vol. 04 No. 33 | August 18, 1978

Download PDF Visit The Full Archive

Related Articles

In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years

October 7, 1977

Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.

December 19, 2008

U.S. Tobacco Program Loses $505 il. In Loan Principle, Report Finds

January 5, 1990

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

DCT Board Insists On Being Heard In Development Of CCOP Guidelines

February 19, 1982

Chi Van Dang Named Director of University Of Pennsylvania Abramson Cancer Center

July 15, 2011